The KRAS-variant and treatment response in BATTLE-1.

被引：2
|
作者：
Weidhaas, Joanne B.
Kim, Edward S.
Herbst, Roy S.
Yu, Jun
Slack, Frank
Blumenschein, George R.
Tsao, Anne S.
Wistuba, Ignacio Ivan
Lee, J. Jack
Papadimitrakopoulou, Vassiliki
Hong, Waun Ki
Heymach, John
Tran, Hai T.
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC USA
[3] Yale Univ, Sch Med, Dept Med Oncol, New Haven, CT USA
[4] MDACC, Houston, TX USA
[5] Yale Univ, New Haven, CT USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[8] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.8135
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8135
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia
    Moessner, Rainald
    Schuhmacher, Anna
    Kuehn, Kai-Uwe
    Cvetanovska, Gabriela
    Rujescu, Dan
    Zill, Peter
    Quednow, Boris B.
    Rietschel, Marcella
    Woelwer, Wolfgang
    Gaebel, Wolfgang
    Wagner, Michael
    Maier, Wolfgang
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (01): : 91 - 94
  • [32] Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications
    Ricciuti, Biagio
    Leonardi, Giulia Costanza
    Metro, Giulio
    Grignani, Francesco
    Paglialunga, Luca
    Bellezza, Guido
    Baglivo, Sara
    Mencaroni, Clelia
    Baldi, Alice
    Zicari, Daniela
    Crino, Lucio
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (01) : 53 - 68
  • [33] Genetic variant may predict response to treatment for infertility syndrome
    不详
    PHARMACOGENOMICS, 2008, 9 (05) : 499 - 499
  • [34] A case report of an unusual non-mucinous papillary variant of CPAM type 1 with KRAS mutations
    Timco Koopman
    Bart L. Rottier
    Arja ter Elst
    Wim Timens
    BMC Pulmonary Medicine, 20
  • [35] A case report of an unusual non-mucinous papillary variant of CPAM type 1 with KRAS mutations
    Koopman, Timco
    Rottier, Bart L.
    ter Elst, Arja
    Timens, Wim
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [36] Near Complete Response to Trametinib Treatment in Histiocytic Sarcoma Harboring a Somatic KRAS Mutation
    Hu, Boyu
    Patel, Jay L.
    Tao, Randa
    Cannon, Richard B.
    Monroe, Marcus
    Goyal, Gaurav
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (06): : 618 - 621
  • [37] Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment
    Kitagawa, Yoshiyasu
    Okumura, Kazuhiro
    Watanabe, Takayoshi
    Tsukamoto, Kei
    Kitano, Shiro
    Nankinzan, Rino
    Suzuki, Takuto
    Hara, Taro
    Soda, Hiroaki
    Denda, Tadamichi
    Yamaguchi, Taketo
    Nagase, Hiroki
    SCIENTIFIC REPORTS, 2019, 9 (1) : 11346
  • [38] Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment
    Yoshiyasu Kitagawa
    Kazuhiro Okumura
    Takayoshi Watanabe
    Kei Tsukamoto
    Shiro Kitano
    Rino Nankinzan
    Takuto Suzuki
    Taro Hara
    Hiroaki Soda
    Tadamichi Denda
    Taketo Yamaguchi
    Hiroki Nagase
    Scientific Reports, 9
  • [39] KRAS mutations in Slovene patients with colorectal cancer: frequency, distribution and correlation with the response to treatment
    Licar, Alenka
    Cerkovnik, Petra
    Ocvirk, Janja
    Novakovic, Srdjan
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 36 (05) : 1137 - 1144
  • [40] JN.1 and the ongoing battle: unpacking the characteristics of a new dominant COVID-19 variant
    Eshraghi, Reza
    Bahrami, Ashkan
    Karimi Houyeh, Motahare
    Nasr Azadani, Maryam
    PATHOGENS AND GLOBAL HEALTH, 2024,
12345